Oak Ridge Investments LLC Novartis Ag Transaction History

Oak Ridge Investments LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$82.14 - $91.0 $458,916 - $508,417	-5,587 Closed	0 $0
Q2 2020 Aug 05, 2020	BUY	$80.93 - $91.1 $14,324 - $16,124	177 Added 3.27%	5,587 $488,000
Q1 2020 May 13, 2020	SELL	$70.67 - $99.01 $33,426 - $46,831	-473 Reduced 8.04%	5,410 $446,000
Q4 2019 Feb 05, 2020	SELL	$84.35 - $95.37 $66,046 - $74,674	-783 Reduced 11.75%	5,883 $557,000
Q2 2019 Aug 14, 2019	SELL	$75.4 - $92.8 $1,809 - $2,227	-24 Reduced 0.36%	6,666 $608,000
Q4 2018 Feb 11, 2019	SELL	$73.66 - $82.02 $9,133 - $10,170	-124 Reduced 1.82%	6,690 $574,000
Q3 2018 Nov 07, 2018	BUY	$66.94 - $77.43 $28,717 - $33,217	429 Added 6.72%	6,814 $587,000
Q2 2018 Aug 13, 2018	BUY	$64.91 - $73.36 $23,562 - $26,629	363 Added 6.03%	6,385 $482,000
Q1 2018 May 14, 2018	SELL	$70.39 - $84.15 $3,871 - $4,628	-55 Reduced 0.91%	6,022 $487,000
Q4 2017 Feb 13, 2018	BUY	$72.33 - $77.64 $439,549 - $471,818	6,077	6,077 $510,000

1,437

131M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $209B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Oak Ridge Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Oak Ridge Investments LLC with notifications on news.